Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
PAVmed Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
PAVM
Nasdaq
3840
www.pavmed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for PAVmed Inc.
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...
- May 15th, 2026 5:01 pm
PAVmed (PAVM) Q4 2025 Earnings Transcript
- May 15th, 2026 9:36 am
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
- May 15th, 2026 7:15 am
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
- May 15th, 2026 6:00 am
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
- May 14th, 2026 7:20 am
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
- May 14th, 2026 6:00 am
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates
- May 13th, 2026 4:40 pm
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates
- May 12th, 2026 3:40 pm
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
- May 8th, 2026 8:00 am
Alphatec (ATEC) Reports Break-Even Earnings for Q1
- May 5th, 2026 4:05 pm
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
- May 1st, 2026 6:31 am
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
- Apr 30th, 2026 6:31 am
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
- Apr 29th, 2026 3:45 pm
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset
- Apr 27th, 2026 6:04 am
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
- Apr 24th, 2026 8:23 am
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
- Apr 23rd, 2026 6:30 am
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
- Apr 9th, 2026 6:01 am
How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment
- Apr 8th, 2026 7:20 pm
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch
- Apr 7th, 2026 9:01 am
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
- Apr 2nd, 2026 6:01 am
Scroll